Skip to main content

Brexit and the implications for UK business: Pharmaceuticals inquiry


This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry.

The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, R&D, trade opportunities and transitional arrangements.